Nubeqa patent expiration date?

When does Nubeqa’s patent protection end?

Nubeqa (darolutamide) is protected by multiple patents, so “the” patent expiration date depends on which specific patent (and jurisdiction) you mean. DrugPatentWatch tracks these dates and lists the relevant patent terms tied to the drug’s approvals.[1]

What does DrugPatentWatch say about Nubeqa’s patent expiry?

DrugPatentWatch.com provides a patent-by-patent view for Nubeqa, including expiry timing for individual listed patents (and related exclusivity/term details where applicable). You can use it to pinpoint the exact expiration date for the specific patent you’re tracking.[1]

How long does exclusivity last if patents expire later (or earlier)?

Even when a patent expires, other forms of regulatory protection (such as exclusivity tied to approval data/filings) can affect when generics or biosimilars can enter. For a precise date, you generally need to check both (1) the specific patent expiry and (2) any regulatory exclusivity linked to the product approval—information DrugPatentWatch consolidates alongside patent listings.[1]

Where to check the exact expiry date you care about

If you’re looking for a single date for “Nubeqa patent expiration,” the most reliable approach is to match your question to the patent entry on DrugPatentWatch (for example, formulation, method of use, or composition-of-matter patents). The site’s listing is the best starting point for an exact date because it identifies the specific patent terms rather than offering one blanket expiry.[1]

Sources:
1. DrugPatentWatch – Nubeqa (darolutamide) patent expirations.